A Phase I/II Trial of Definitive Carbon Ion Radiotherapy for Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma

Affiliations

• ¹ National Institutes for Quantum Science and Technology, QST Hospital, Chiba, Japan; Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan. Electronic address: isozaki.tetsuro@qst.go.jp.
• ² National Institutes for Quantum Science and Technology, QST Hospital, Chiba, Japan.
• ³ National Institutes for Quantum Science and Technology, QST Hospital, Chiba, Japan; Department of Radiology, Chiba Rosai Hospital, Chiba, Japan.
• ⁴ Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan; Miwa Central Clinic, Mito, Japan.
• ⁵ Division of Esophago-Gastrointestinal Surgery, Chiba Cancer Center, Chiba, Japan; Department of Surgery, Tojo Hospital, Chiba, Japan.
• ⁶ Division of Esophago-Gastrointestinal Surgery, Chiba Cancer Center, Chiba, Japan.
• ⁷ Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan.
• ⁸ Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
• ⁹ Department of General Surgical Science, Graduate School of Medicine, Gunma University, Gunma, Japan.
• ¹⁰ Department of Radiation Oncology, Yamagata University, Yamagata, Japan.
• ¹¹ Department of Diagnostic Radiology & Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.